specific infections Flashcards
Pharingitis, Tonsillitis
– Potential pathogen: Viral, S. pyogenes, (other Streptococcis, C. diphteriae, Gonococci etc.)
– Therapy: Penicillin V, Aminopenicillins, I. gen Cephalosporins, Macrolids, Clindamycin
Sinusitis, Otitis media:
– Potential pathogen: Pneumococci, H. influenzae, Moraxella catarrhalis, Staphylococci aureus, Anaerobes, Streptococci species
– Therapy: Amoxicilline-Clavulanic acid, Cefuroxime, Cefprozil, Macrolide, III. gen. Fluoroquinolones, Doxycycline
Bronchitis
• Acute:
– Potential pathogen: Viral, M. pneumoniae, C. pneumoniae, B. pertussis
– Therapy (if it is necessary): Macrolides
• Chronic with acute exacerbation:
– Potential pathogen: H. influenzae, Moraxella, and Streptococcus pneumoniae
– Therapy: Macrolides, Amoxicilline-Clavulanic acid, II. gen Cephalosporine,
III. gen Fluoroquinolones
Risk of Pseudomonas (Bronchitis)
Fluoroquinolons+ Amoxycilline, Piperacilline-Tazobactam, Ceftazidime, Meropenem
Community acquired pneumonia, Without comorbidity, <65 :
– Potential pathogen : Pneumococci, H. influenzae, M. pneumoniae, C. pneumoniae, viruses (sometimes: Legionella, S. aureus, aerob Gr- rods, TBC)
– Therapy: Amoxicillin-Clavulanic acid (Amox-Clav), Macrolids, Cefuroxim-axetil,
Community acquired pneumonia, Middle severe comorbidities or >65 :
– Potential pathogen : Pneumococci, H. influenzae, aerob Gr- rods, S. aureus, C. pneumoniae (M. catarhalis, Legionella, TBC)
– Therapy: po.: Amox-Clav or Cefuroxim-axetil ± Macrolid, 3. gen. Fluoroquinolones (FQ); iv: Ceftriaxone/ Cefuroxim ± Macrolid
Community acquired pneumonia, Hospitalisation is required:
– Potential pathogen: Pneumococci, H. influenzae, aerob Gr- rods, Legionella, S. aureus, C. pneumoniae, polymicrobal inf. with anaerobs, viral (M. pneumoniae, M. catarhalis, TBC)
– Therapy: iv: Amox-Clav, Amp-Sulb, cefuroxime, ceftriaxone/cefotaxime + macrolid, 3 gen. FQ. If suspected anaerob infection: cephalosporins + clindamycin / metronidazol, moxifloxacin
Community acquired pneumonia, Very severe (ICU treatment)
– Potential pathogen: Pneumococci, Legionella, S. aureus, Gr- rods, M. pneumoniae, Viral (H. influenzae, TBC)
– Therapy:
• If Pseudomonas is not suspected: Ceftriaxone/cefotaxime/ertapenem + Macrolid or 3 gen. FQ
• If Pseudomonas is suspected: Ceftazidime, Cefepime, Carbapenems, Piperacillin-Tazobactam + Macrolids or Fluoroquinolones ± Aminoglycozides
Urinary tract infections
Women - uncomplicated cystitis
– Potential pathogen: E. coli, Staphylococci Saprophyticus, Proteus, Klebsiella, E. faecalis
– Therapy: Nitrofurantoin, Fosfomycin-trometamol, Cotrimoxazol (Res!), Fluoroquinolons (Res!!), oral 3. gen cephalosporins
Urinary tract infections
Women - uncomplicated acute pyelonephritis
– Potential pathogen: E. coli (Proteus, Klebsiella, S. saprophyticus)
– Therapy: 2-3 gen. parent. cephalosporinok, 3. gen. oral cephalosporins, Amox-Clav (iv. Amp-Sul), aminoglycosid, 2. gen. Fluoroquinolones (Res!)
Urinary tract infections
Complicated urinary tract infections (in case of men is always complicated)
– Potential pathogen: E. Coli, Klebsiella, Pseudomonas, Enterobacter, other Enterobacteriaceae, Enterococci, S. epidermidis (Microbiol. diagnosis is important)
– Therapy: 2-3-4 gen Cephalosporins, Aminoglycosids, Carbapenems (ESBL), Fluoroquinolons (Res!!)
Intraabdominal infections
Colecystitis
– Potential pathogen: Enterobacteriaceae (most common. E. coli), Klebsiella, Enterobacter), Enterococci, Anaerobs, Clostridium strains
– Therapy: 3-4 gen. Cephalosporins + metronidazole/clindamycin, Piperacillin-Tazo (pip- tazo), carbapenems
– The resistancy is very changeable; the ESBL is very common (Klebsiella)
Intraabdominal infections
Spontaneous bacterial peritonitis
– Potential pathogen: Enterobacteriaceae, Enterococci
– Therapy: 3 gen cephalosporins, Pip-Tazo, carbapenems, ofloxacin/ciprofloxacin
Intraabdominal infections
Secondary surgical peritonitis (non nosocomial)
– Potential pathogen: E. coli , K. pneumoniae + anaerobs (B. fragilis)
– Therapy: Ceftriaxone+Metronidazol, Pip-Tazo, Carbapenems
Intraabdominal infections
Secondary surgical peritonitis (nosocomial)
– Potential pathogen: Multiresistant GI bacterias (E. coli, Klebsiella, Enterobacter), Pseudomonas, Acinetobacter, Enterococci
– Therapy: Carbapenems±aminogylcosides, 3-4. gen Cephalosporins+Metronidazole ± Vancomycin. VRE: tigecyclin, linezolid, MACI: colistin